SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : INHL - Inhale Therapeutics - Pulmonary Insulin!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (56)12/19/1997 2:06:00 PM
From: Rick Costantino  Read Replies (1) of 225
 
Jim,

Funny, I am thinking the exact same thing. I will be tax loss selling next week and I will probably pick up some INHL again. Although, the market looks extremely rocky right now, and I may may waiy a few more weeks. I am looking for a dip below $24, and we are almost there.

With insulin in Phase III, it could be a big hit. Even if it doesn't pan out, there are other trials going on as well.

I don't see any conflict betweem INHL and ARDM (I do not have shares of eitherm, by the way). ARDM is very early on, probably a year or two away from trials. ARDM's device is a hand held liquid nebulizer, whereas INHL's uses a powder dispersed as an aerosol cloud. Actually, ARDM device is potentially smaller and more efficient. However, it is much more difficult to formulate drugs (particularly proteins) in the liquid state (solid state powders are much more stable).

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext